Table 1 Clinical and demographic characteristics and comparison between SMI and control subjects
SMI n = 301 | Control n = 200 | p value* | |
|---|---|---|---|
Age years mean (SD) | 40.1 (9.9) | 39.35 (10.3) | 0.43 |
Male n (%) | 182 (60.5) | 124 (62.0) | 0.73 |
Pupil size, mm mean (SD) | 3.79 (1.14) | 3.80 (1.01) | 0.90 |
Diagnosis, n (%) | |||
Schizophrenia | 150 (49.8) | – | – |
Bipolar disorder | 151 (50.2) | – | – |
Duration of illness, years mean (SD) | 26.9 (8.0) | – | – |
Medication, n (%) | |||
Olanzapine | 45 (14.9) | – | – |
Quetiapine | 77 (25.6) | – | – |
Clozapine | 49 (16.3) | – | – |
Risperidone | 55 (18.3) | – | – |
Lithium | 73 (24.3) | – | – |
Aripiprazole | 35 (11.6) | – | – |
Synthroid | 27 (8.9) | – | – |